Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se


Albergo, J. I., Gaston, C. L. L., Parry, M. C., Laitinen, M. K., Jeys, L. M., Tillman, R. M., . . . Grimer, R. J. (2018). Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered? Bone Joint J, 100-b(2), 247-255. doi:10.1302/0301-620x.100b2.bjj-2017-0222.r1

Alektiar, K. M., Brennan, M. F., Healey, J. H., & Singer, S. (2008). Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol, 26(20), 3440-3444. doi:10.1200/JCO.2008.16.6249

Angervall, L., & Kindblom, L. G. (1993). Principles for pathologic-anatomic diagnosis and classification of soft-tissue sarcomas. Clin Orthop Relat Res(289), 9-18. 

Azzarelli, A., Gronchi, A., Bertulli, R., Tesoro, J. D., Baratti, D., Pennacchioli, E., . . . Casali, P. G. (2001). Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer, 92(5), 1259-1264. 

Ballinger, M. L., Goode, D. L., Ray-Coquard, I., James, P. A., Mitchell, G., Niedermayr, E., . . . International Sarcoma Kindred, S. (2016). Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol, 17(9), 1261-1271. doi:10.1016/S1470-2045(16)30147-4

Bastiaannet, E., Groen, H., Jager, P. L., Cobben, D. C., van der Graaf, W. T., Vaalburg, W., & Hoekstra, H. J. (2004). The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev, 30(1), 83-101. doi:10.1016/j.ctrv.2003.07.004

Bauer, H. C., Trovik, C. S., Alvegard, T. A., Berlin, O., Erlanson, M., Gustafson, P., . . . Wiklund, T. (2001). Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand, 72(2), 150-159. doi:10.1080/000164701317323408

Becker, G., & Bottke, D. (2006). Radiotherapy in the management of Kaposi's sarcoma. Onkologie, 29(7), 329-333. doi:10.1159/000093660

Bhangu, A. A., Beard, J. A., & Grimer, R. J. (2004). Should Soft Tissue Sarcomas be Treated at a Specialist Centre? Sarcoma, 8(1), 1-6. doi:10.1080/13577140410001679185

Blackmon, S. H., Shah, N., Roth, J. A., Correa, A. M., Vaporciyan, A. A., Rice, D. C., . . . Mehran, R. (2009). Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg, 88(3), 877-884; discussion 884-875. doi:10.1016/j.athoracsur.2009.04.144

Bloch, O. G., Jian, B. J., Yang, I., Han, S. J., Aranda, D., Ahn, B. J., & Parsa, A. T. (2010). Cranial chondrosarcoma and recurrence. Skull Base, 20(3), 149-156. doi:10.1055/s-0029-1246218

Borden, E. C., Amato, D. A., Rosenbaum, C., Enterline, H. T., Shiraki, M. J., Creech, R. H., . . . Carbone, P. P. (1987). Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol, 5(6), 840-850. doi:10.1200/JCO.1987.5.6.840

Bradley, K. A., Rubinsky, A. D., Sun, H., Bryson, C. L., Bishop, M. J., Blough, D. K., . . . Kivlahan, D. R. (2011). Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med, 26(2), 162-169. doi:10.1007/s11606-010-1475-x

Broders AC. Squamous-cell epithelioma of the lip: a study of five hundred and thirty-seven cases. J Am Med Assoc 1920;74(10):656-64. 

Carneiro, A., Bendahl, P. O., Engellau, J., Domanski, H. A., Fletcher, C. D., Rissler, P., . . . Nilbert, M. (2011). A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern. Cancer, 117(6), 1279-1287. doi:10.1002/cncr.25621

Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., . . . Blay, J. Y. (2018). Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 29(Suppl 4), iv79-iv95. doi:10.1093/annonc/mdy310

Chugh, R., Dunn, R., Zalupski, M. M., Biermann, J. S., Sondak, V. K., Mace, J. R., . . . Baker, L. H. (2005). Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma. J Clin Oncol, 23(15), 3597-3604. doi:10.1200/JCO.2005.02.170

Coates, M. (2003). Ultrasound and soft-tissue mass lesions--a note of caution. N Z Med J, 116(1187), U706. 

Coindre, J. M., Terrier, P., Bui, N. B., Bonichon, F., Collin, F., Le Doussal, V., . . . Contesso, G. (1996). Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol, 14(3), 869-877. 

Company, E. L. a. (2019). Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO. 

Constantinidou, A., Jones, R. L., Scurr, M., Al-Muderis, O., & Judson, I. (2009). Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer, 45(17), 2930-2934. doi:10.1016/j.ejca.2009.08.016

Cormier, J. N., & Pollock, R. E. (2004). Soft tissue sarcomas. CA Cancer J Clin, 54(2), 94-109. 

D'Angelo, S. P., Munhoz, R. R., Kuk, D., Landa, J., Hartley, E. W., Bonafede, M., . . . Tap, W. D. (2015). Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma. Oncology, 89(4), 205-214. doi:10.1159/000381917

Daigeler, A., Zmarsly, I., Hirsch, T., Goertz, O., Steinau, H. U., Lehnhardt, M., & Harati, K. (2014). Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma. Br J Cancer, 110(6), 1456-1464. doi:10.1038/bjc.2014.21

DeLaney, T. F., Liebsch, N. J., Pedlow, F. X., Adams, J., Weyman, E. A., Yeap, B. Y., . . . Hornicek, F. J. (2014). Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol, 110(2), 115-122. doi:10.1002/jso.23617

DeLaney, T. F., Park, L., Goldberg, S. I., Hug, E. B., Liebsch, N. J., Munzenrider, J. E., & Suit, H. D. (2005). Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys, 61(2), 492-498. doi:10.1016/j.ijrobp.2004.05.051

Demetri, G. D., Chawla, S. P., von Mehren, M., Ritch, P., Baker, L. H., Blay, J. Y., . . . Le Cesne, A. (2009). Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol, 27(25), 4188-4196. doi:10.1200/JCO.2008.21.0088

DuBois, S. G., Krailo, M. D., Gebhardt, M. C., Donaldson, S. S., Marcus, K. J., Dormans, J., . . . Grier, H. E. (2015). Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer, 121(3), 467-475. doi:10.1002/cncr.29065

Duffaud, F., Mir, O., Boudou-Rouquette, P., Piperno-Neumann, S., Penel, N., Bompas, E., . . . Blay, J. Y. (2019). Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol, 20(1), 120-133. doi:10.1016/s1470-2045(18)30742-3

Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980). A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res(153), 106-120. 

European Partnership Action Against Cancer consensus, g., Borras, J. M., Albreht, T., Audisio, R., Briers, E., Casali, P., . . . Wilson, R. (2014). Policy statement on multidisciplinary cancer care. Eur J Cancer, 50(3), 475-480. doi:10.1016/j.ejca.2013.11.012

Evans, H. L., Ayala, A. G., & Romsdahl, M. M. (1977). Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer, 40(2), 818-831. 

Ferrari, S., del Prever, A. B., Palmerini, E., Staals, E., Berta, M., Balladelli, A., . . . Vanel, D. (2009). Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma. Pediatr Blood Cancer, 52(5), 581-584. doi:10.1002/pbc.21917

Franzius, C., Sciuk, J., Daldrup-Link, H. E., Jurgens, H., & Schober, O. (2000). FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med, 27(9), 1305-1311. 

Garcia-Del-Muro, X., Lopez-Pousa, A., Maurel, J., Martin, J., Martinez-Trufero, J., Casado, A., . . . Spanish Group for Research on, S. (2011). Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. J Clin Oncol, 29(18), 2528-2533. doi:10.1200/JCO.2010.33.6107

Geijer, M., Styring, E., Brosjo, O., & Skorpil, M. (2014). [Most musculoskeletal soft tissue tumors are benign]. Lakartidningen, 111(38), 1578-1580. 

Grimer, R., Athanasou, N., Gerrand, C., Judson, I., Lewis, I., Morland, B., . . . Whelan, J. (2010). UK Guidelines for the Management of Bone Sarcomas. Sarcoma, 2010, 317462. doi:10.1155/2010/317462

Grimer, R., Judson, I., Peake, D., & Seddon, B. (2010). Guidelines for the management of soft tissue sarcomas. Sarcoma, 2010, 506182. doi:10.1155/2010/506182

Grimer, R. J. (2006). Size matters for sarcomas! Ann R Coll Surg Engl, 88(6), 519-524. doi:10.1308/003588406X130651

Grimer, R. J., Carter, S. R., Tillman, R. M., & Abudu, A. (2001). Early symptoms and diagnosis of bone tumors. J Bone Joint Surg Am, 83-A(7), 1107-1108. 

Grimer, R. J., & Sneath, R. S. (1990). Diagnosing malignant bone tumours. J Bone Joint Surg Br, 72(5), 754-756. 

Group, E. E. S. N. W. (2012). Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23 Suppl 7, vii100-109. doi:10.1093/annonc/mds254

Group, E. S. E. S. N. W. (2014). Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 25 Suppl 3, iii102-112. doi:10.1093/annonc/mdu254

Guillou, L., Coindre, J. M., Bonichon, F., Nguyen, B. B., Terrier, P., Collin, F., . . . Costa, J. (1997). Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol, 15(1), 350-362. 

Gustafson, P. (1994). Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl, 259, 1-31. 

Gustafson, P., Akerman, M., Alvegard, T. A., Coindre, J. M., Fletcher, C. D., Rydholm, A., & Willen, H. (2003). Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system. Eur J Cancer, 39(11), 1568-1576. 

Gustafson, P., Dreinhofer, K. E., & Rydholm, A. (1994). Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand, 65(1), 47-50. 

Gutierrez, J. C., Perez, E. A., Moffat, F. L., Livingstone, A. S., Franceschi, D., & Koniaris, L. G. (2007). Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg, 245(6), 952-958. doi:10.1097/01.sla.0000250438.04393.a8

Hunold, A., Weddeling, N., Paulussen, M., Ranft, A., Liebscher, C., & Jurgens, H. (2006). Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors. Pediatr Blood Cancer, 47(6), 795-800. doi:10.1002/pbc.20719

Hurley, C., McCarville, M. B., Shulkin, B. L., Mao, S., Wu, J., Navid, F., . . . Bishop, M. W. (2016). Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Pediatr Blood Cancer, 63(8), 1381-1386. doi:10.1002/pbc.26014

Iwakawa, M., Noda, S., Yamada, S., Yamamoto, N., Miyazawa, Y., Yamazaki, H., . . . Imai, T. (2006). Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer, 13(3), 300-307. 

Jagsi, R., Griffith, K. A., Koelling, T., Roberts, R., & Pierce, L. J. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 109(4), 650-657. doi:10.1002/cncr.22452

Jebsen, N. L., Bruland, O. S., Eriksson, M., Engellau, J., Turesson, I., Folin, A., . . . Hall, K. S. (2011). Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. Int J Radiat Oncol Biol Phys, 81(5), 1359-1366. doi:10.1016/j.ijrobp.2010.07.037

Jian, B. J., Bloch, O. G., Yang, I., Han, S. J., Aranda, D., Tihan, T., & Parsa, A. T. (2010). Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. J Neurooncol, 98(1), 101-108. doi:10.1007/s11060-009-0068-1

Johnson, C. J., Pynsent, P. B., & Grimer, R. J. (2001). Clinical features of soft tissue sarcomas. Ann R Coll Surg Engl, 83(3), 203-205. 

Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schoffski, P., Blay, J. Y., . . . Bone Sarcoma, G. (2014). Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol, 15(4), 415-423. doi:10.1016/S1470-2045(14)70063-4

Katz, D., Boonsirikamchai, P., Choi, H., Lazar, A. J., Wang, W. L., Xiao, L., . . . Araujo, D. M. (2012). Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res, 2(1), 2. doi:10.1186/2045-3329-2-2

Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008). Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol, 26(3), 392-398. doi:10.1200/JCO.2007.13.3033

Kim, H. S., Bindiganavile, S. S., & Han, I. (2015). Oncologic outcome after local recurrence of chondrosarcoma: Analysis of prognostic factors. J Surg Oncol, 111(8), 957-961. doi:10.1002/jso.23925

King, D. M., Hackbarth, D. A., Kilian, C. M., & Carrera, G. F. (2009). Soft-tissue sarcoma metastases identified on abdomen and pelvis CT imaging. Clin Orthop Relat Res, 467(11), 2838-2844. doi:10.1007/s11999-009-0989-1

Komplementär och alternativ medicin (KAM). Retrieved from https://www.cancercentrum.se/stockholm-gotland/om-oss/nyheter/2016/januari/ny-broschyr/

La, T. H., Meyers, P. A., Wexler, L. H., Alektiar, K. M., Healey, J. H., Laquaglia, M. P., . . . Wolden, S. L. (2006). Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys, 64(2), 544-550. doi:10.1016/j.ijrobp.2005.07.299

Leithner, A., Schnack, B., Katterschafka, T., Wiltschke, C., Amann, G., Windhager, R., . . . Zielinski, C. C. (2000). Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol, 73(1), 21-25. 

Lipplaa, A., Dijkstra, S., & Gelderblom, H. (2016). Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series. Clin Sarcoma Res, 6, 19. doi:10.1186/s13569-016-0059-x

Liu, X. W., Zi, Y., Xiang, L. B., & Han, T. Y. (2015). Periosteal osteosarcoma: a review of clinical evidence. Int J Clin Exp Med, 8(1), 37-44. 

Loh, A. H., Navid, F., Wang, C., Bahrami, A., Wu, J., Neel, M. D., & Rao, B. N. (2014). Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery. Ann Surg Oncol, 21(6), 1948-1955. doi:10.1245/s10434-014-3550-8

Lorigan, P., Verweij, J., Papai, Z., Rodenhuis, S., Le Cesne, A., Leahy, M. G., . . . Bone Sarcoma Group, S. (2007). Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol, 25(21), 3144-3150. doi:10.1200/JCO.2006.09.7717

Macdonald, G., Kondor, N., Yousefi, V., Green, A., Wong, F., & Aquino-Parsons, C. (2004). Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen. Radiother Oncol, 73(3), 367-371. doi:10.1016/j.radonc.2004.09.002

Mai, P. L., Best, A. F., Peters, J. A., DeCastro, R. M., Khincha, P. P., Loud, J. T., . . . Savage, S. A. (2016). Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer, 122(23), 3673-3681. doi:10.1002/cncr.30248

Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., . . . Whelan, J. S. (2016). Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol, 17(10), 1396-1408. doi:10.1016/S1470-2045(16)30214-5

Mertens, F., & Tayebwa, J. (2014). Evolving techniques for gene fusion detection in soft tissue tumours. Histopathology, 64(1), 151-162. doi:10.1111/his.12272

Meyer, J. S., Nadel, H. R., Marina, N., Womer, R. B., Brown, K. L., Eary, J. F., . . . Kailo, M. D. (2008). Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer, 51(2), 163-170. doi:10.1002/pbc.21596

Miller, T. T. (2008). Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology, 246(3), 662-674. doi:10.1148/radiol.2463061038

Moser, R. P., Jr., & Madewell, J. E. (1987). An approach to primary bone tumors. Radiol Clin North Am, 25(6), 1049-1093. 

Moureau-Zabotto, L., Thomas, L., Bui, B. N., Chevreau, C., Stockle, E., Martel, P., . . . Delannes, M. (2004). [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases]. Cancer Radiother, 8(5), 279-287. doi:10.1016/j.canrad.2004.07.004

Nath, B., Li, Y., Carroll, J. E., Szabo, G., Tseng, J. F., & Shah, S. A. (2010). Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg, 14(11), 1732-1741. doi:10.1007/s11605-010-1350-4

O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., . . . Zee, B. (2002). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet, 359(9325), 2235-2241. doi:10.1016/S0140-6736(02)09292-9

O'Sullivan, B., Gullane, P., Irish, J., Neligan, P., Gentili, F., Mahoney, J., . . . Bell, R. (2003). Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series. World J Surg, 27(7), 875-883. 

Palmerini, E., Jones, R. L., Setola, E., Picci, P., Marchesi, E., Luksch, R., . . . Ferrari, S. (2018). Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients. Acta Oncol, 57(7), 958-964. doi:10.1080/0284186x.2018.1449250

Park, M. S., Patel, S. R., Ludwig, J. A., Trent, J. C., Conrad, C. A., Lazar, A. J., . . . Araujo, D. M. (2011). Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer, 117(21), 4939-4947. doi:10.1002/cncr.26098

Park, M. S., Ravi, V., Conley, A., Patel, S. R., Trent, J. C., Lev, D. C., . . . Araujo, D. M. (2013). The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res, 3(1), 7. doi:10.1186/2045-3329-3-7

Patel, S. R., & Benjamin, R. S. (2006). Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol, 24(1), 11-12. doi:10.1200/JCO.2005.03.6566

Penel, N., Bui, B. N., Bay, J. O., Cupissol, D., Ray-Coquard, I., Piperno-Neumann, S., . . . Blay, J. Y. (2008). Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol, 26(32), 5269-5274. doi:10.1200/JCO.2008.17.3146

Penel, N., Le Cesne, A., Bui, B. N., Perol, D., Brain, E. G., Ray-Coquard, I., . . . Blay, J. Y. (2011). Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol, 22(2), 452-457. doi:10.1093/annonc/mdq341

Picci, P., Rougraff, B. T., Bacci, G., Neff, J. R., Sangiorgi, L., Cazzola, A., . . . et al. (1993). Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol, 11(9), 1763-1769. 

Pillay, B., Wootten, A. C., Crowe, H., Corcoran, N., Tran, B., Bowden, P., . . . Costello, A. J. (2016). The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev, 42, 56-72. doi:10.1016/j.ctrv.2015.11.007

Pisters, P. W., Harrison, L. B., Leung, D. H., Woodruff, J. M., Casper, E. S., & Brennan, M. F. (1996). Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol, 14(3), 859-868. 

Pretell-Mazzini, J., Barton, M. D., Jr., Conway, S. A., & Temple, H. T. (2015). Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis. J Bone Joint Surg Am, 97(7), 597-603. doi:10.2106/JBJS.N.00649

Prochazka, M., Granath, F., Ekbom, A., Shields, P. G., & Hall, P. (2002). Lung cancer risks in women with previous breast cancer. Eur J Cancer, 38(11), 1520-1525. 

Rapkin, L., Qayed, M., Brill, P., Martin, M., Clark, D., George, B. A., . . . Katzenstein, H. M. (2012). Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas. Pediatr Blood Cancer, 59(5), 854-858. doi:10.1002/pbc.24101

Rastrelli, M., Tropea, S., Basso, U., Roma, A., Maruzzo, M., & Rossi, C. R. (2014). Soft tissue limb and trunk sarcomas: diagnosis, treatment and follow-up. Anticancer Res, 34(10), 5251-5262. 

Ray-Coquard, I. L., Domont, J., Tresch-Bruneel, E., Bompas, E., Cassier, P. A., Mir, O., . . . Penel, N. (2015). Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial. J Clin Oncol, 33(25), 2797-2802. doi:10.1200/JCO.2015.60.8505

Regnier-Rosencher, E., Guillot, B., & Dupin, N. (2013). Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol, 68(2), 313-331. doi:10.1016/j.jaad.2012.04.018

Rothermundt, C., Whelan, J. S., Dileo, P., Strauss, S. J., Coleman, J., Briggs, T. W., . . . Seddon, B. M. (2014). What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer, 110(10), 2420-2426. doi:10.1038/bjc.2014.200

Rydholm, A. (1983). Management of patients with soft-tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand Suppl, 203, 13-77. 

Rydholm, A. (1998). Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres. BMJ, 317(7151), 93-94. 

Salzer-Kuntschik, M., Delling, G., Beron, G., & Sigmund, R. (1983). Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80. J Cancer Res Clin Oncol, 106 Suppl, 21-24. 

Sanfilippo, R., Dileo, P., Blay, J. Y., Constantinidou, A., Le Cesne, A., Benson, C., . . . Casali, P. G. (2015). Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network. Anticancer Drugs, 26(6), 678-681. doi:10.1097/CAD.0000000000000228

Schoffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., . . . Patel, S. R. (2016). Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet, 387(10028), 1629-1637. doi:10.1016/S0140-6736(15)01283-0

Schwarz, R., Bruland, O., Cassoni, A., Schomberg, P., & Bielack, S. (2009). The role of radiotherapy in oseosarcoma. Cancer Treat Res, 152, 147-164. doi:10.1007/978-1-4419-0284-9_7

Seddon, B., Scurr, M., Jones, R. L., Wood, Z., Propert-Lewis, C., Fisher, C., . . . Judson, I. (2015). A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma. Clin Sarcoma Res, 5, 13. doi:10.1186/s13569-015-0029-8

Sharp LJ, H. Hatschek, T. Bergenmar, M. Smoking and other risk factors for the development of severe acute radiation skin reactions in women with breast cancer undergoing radiotherapy. . In press december 2012. 

Stacchiotti, S., Longhi, A., Ferraresi, V., Grignani, G., Comandone, A., Stupp, R., . . . Casali, P. G. (2012). Phase II study of imatinib in advanced chordoma. J Clin Oncol, 30(9), 914-920. doi:10.1200/JCO.2011.35.3656

Stacchiotti, S., Negri, T., Libertini, M., Palassini, E., Marrari, A., De Troia, B., . . . Casali, P. G. (2012). Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol, 23(12), 3171-3179. doi:10.1093/annonc/mds143

Stacchiotti, S., Palassini, E., Sanfilippo, R., Vincenzi, B., Arena, M. G., Bochicchio, A. M., . . . Casali, P. G. (2012). Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol, 23(2), 501-508. doi:10.1093/annonc/mdr066

Stacchiotti, S., Tamborini, E., Lo Vullo, S., Bozzi, F., Messina, A., Morosi, C., . . . Casali, P. G. (2013). Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol, 24(7), 1931-1936. doi:10.1093/annonc/mdt117

Stacchiotti, S., Tamborini, E., Marrari, A., Brich, S., Rota, S. A., Orsenigo, M., . . . Pilotti, S. (2009). Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin Cancer Res, 15(3), 1096-1104. doi:10.1158/1078-0432.CCR-08-2050

Steffner, R. J., & Jang, E. S. (2018). Staging of Bone and Soft-tissue Sarcomas. J Am Acad Orthop Surg, 26(13), e269-e278. doi:10.5435/jaaos-d-17-00055

Strander, H., Turesson, I., & Cavallin-Stahl, E. (2003). A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol, 42(5-6), 516-531. 

Styring, E., Billing, V., Hartman, L., Nilbert, M., Seinen, J. M., Veurink, N., . . . Rydholm, A. (2012). Simple guidelines for efficient referral of soft-tissue sarcomas: a population-based evaluation of adherence to guidelines and referral patterns. J Bone Joint Surg Am, 94(14), 1291-1296. doi:10.2106/JBJS.K.01271

Sundby Hall, K., Bruland, O. S., Bjerkehagen, B., Zaikova, O., Engellau, J., Hagberg, O., . . . Eriksson, M. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). Eur J Cancer, 99, 78-85. doi:10.1016/j.ejca.2018.05.011

Thenappan, A., Halaweish, I., Mody, R. J., Smith, E. A., Geiger, J. D., Ehrlich, P. F., . . . Newman, E. A. (2017). Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer, 64(2), 254-258. doi:10.1002/pbc.26201

Thompson, M. J., Ross, J., Domson, G., & Foster, W. (2015). Screening and surveillance CT abdomen/pelvis for metastases in patients with soft-tissue sarcoma of the extremity. Bone Joint Res, 4(3), 45-49. doi:10.1302/2046-3758.43.2000337

Tinkle, C. L., Weinberg, V., Braunstein, S. E., Wustrack, R., Horvai, A., Jahan, T., . . . Gottschalk, A. R. (2015). Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma. Sarcoma, 2015, 913565. doi:10.1155/2015/913565

Tonnesen, H., Nielsen, P. R., Lauritzen, J. B., & Moller, A. M. (2009). Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth, 102(3), 297-306. doi:10.1093/bja/aen401

Torres, M. A., Ballo, M. T., Butler, C. E., Feig, B. W., Cormier, J. N., Lewis, V. O., . . . Zagars, G. K. (2007). Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys, 67(4), 1124-1129. doi:10.1016/j.ijrobp.2006.10.036

Trovik, C. S., Bauer, H. C., Alvegard, T. A., Anderson, H., Blomqvist, C., Berlin, O., . . . Walloe, A. (2000). Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer, 36(6), 710-716. 

Wagner, A. J., Malinowska-Kolodziej, I., Morgan, J. A., Qin, W., Fletcher, C. D., Vena, N., . . . Maki, R. G. (2010). Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol, 28(5), 835-840. doi:10.1200/JCO.2009.25.2981

Valentin, T., Fournier, C., Penel, N., Bompas, E., Chaigneau, L., Isambert, N., & Chevreau, C. (2013). Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO). Invest New Drugs, 31(6), 1626-1627. doi:10.1007/s10637-013-0023-z

van der Graaf, W. T., Blay, J. Y., Chawla, S. P., Kim, D. W., Bui-Nguyen, B., Casali, P. G., . . . group, P. s. (2012). Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 379(9829), 1879-1886. doi:10.1016/S0140-6736(12)60651-5

Weber, D. C., Malyapa, R., Albertini, F., Bolsi, A., Kliebsch, U., Walser, M., . . . Schneider, R. (2016). Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol, 120(1), 169-174. doi:10.1016/j.radonc.2016.05.011

Weiss, A. J., Horowitz, S., & Lackman, R. D. (1999). Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol, 22(2), 193-195. 

Wells, M., Macmillan, M., Raab, G., MacBride, S., Bell, N., MacKinnon, K., . . . Munro, A. (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73(2), 153-162. doi:10.1016/j.radonc.2004.07.032

Werier, J., Yao, X., Caudrelier, J. M., Di Primio, G., Ghert, M., Gupta, A. A., . . . Verma, S. (2016). A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy. Surg Oncol, 25(1), 16-23. doi:10.1016/j.suronc.2015.11.002

Widhe, B., & Widhe, T. (2000). Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am, 82(5), 667-674. 

Winter, S., Fasola, S., Brisse, H., Mosseri, V., & Orbach, D. (2015). Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy. Pediatr Blood Cancer, 62(11), 1935-1941. doi:10.1002/pbc.25622

Wode, K., Henriksson, R., Sharp, L., Stoltenberg, A., & Hok Nordberg, J. (2019). Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med, 19(1), 62. doi:10.1186/s12906-019-2452-5

Volkova, M., & Russell, R., 3rd. (2011). Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev, 7(4), 214-220. 

Vårdplaneringsgruppen för Solida Tumörer hos Barn (VSTB). Retrieved from http://www.blf.net/onko/page1/index.html

Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., . . . Rosenberg, S. A. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol, 16(1), 197-203. 

Zaikova, O., Sundby Hall, K., Styring, E., Eriksson, M., Trovik, C. S., Bergh, P., . . . Bauer, H. C. (2015). Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia-SSG Central Register 25 years' experience. J Surg Oncol, 112(8), 853-860. doi:10.1002/jso.24074

Nästa kapitel
22 Vårdprogramgruppen